Your browser doesn't support javascript.
loading
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study.
Yekedüz, Emre; Tural, Deniz; Ertürk, Ismail; Karakaya, Serdar; Erol, Cihan; Ercelep, Özlem; Arslan, Çagatay; Sever, Özlem Nuray; Kiliçkap, Saadettin; Sentürk Öztas, Nihan; Küçükarda, Ahmet; Can, Orçun; Öksüzoglu, Berna; Sendur, Mehmet Ali; Karadurmus, Nuri; Ürün, Yüksel.
Afiliación
  • Yekedüz E; Faculty of Medicine Department of Medical Oncology, Ankara University, Cebeci, 06590, Ankara, Turkey.
  • Tural D; Ankara University Cancer Research Institute, Ankara, Turkey.
  • Ertürk I; Department of Medical Oncology, University of Health Sciences, Bakirköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.
  • Karakaya S; Department of Medical Oncology, University of Health Sciences, Gülhane Education and Research Hospital, Ankara, Turkey.
  • Erol C; Medical Oncology Department, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey.
  • Ercelep Ö; Faculty of Medicine, Department of Medical Oncology, Ankara Yildirim Beyazit University, Ankara, Turkey.
  • Arslan Ç; Faculty of Medicine, Department of Medical Oncology, Marmara University, Istanbul, Turkey.
  • Sever ÖN; Faculty of Medicine, Department of Medical Oncology, Izmir University of Economics, Izmir, Turkey.
  • Kiliçkap S; Faculty of Medicine, Department of Medical Oncology, Gaziantep University, Gaziantep, Turkey.
  • Sentürk Öztas N; Faculty of Medicine, Department of Medical Oncology, Hacettepe University, Ankara, Turkey.
  • Küçükarda A; Faculty of Medicine, Department of Medical Oncology, Istinye University, Istanbul, Turkey.
  • Can O; Cerrahpasa Faculty of Medicine, Division of Medical Oncology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Öksüzoglu B; Faculty of Medicine, Department of Medical Oncology, Trakya University, Edirne, Turkey.
  • Sendur MA; Department of Medical Oncology, University of Health Sciences, Prof. Dr. Cemil Tasçioglu City Hospital, Istanbul, Turkey.
  • Karadurmus N; Medical Oncology Department, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey.
  • Ürün Y; Faculty of Medicine, Department of Medical Oncology, Ankara Yildirim Beyazit University, Ankara, Turkey.
J Cancer Res Clin Oncol ; 148(12): 3537-3546, 2022 Dec.
Article en En | MEDLINE | ID: mdl-35616728
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Turquía
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Turquía